natgillin/translations-raw huggingface dataset:
Pursuant to Article 114(6), third subparagraph, TFEU, the period of 6 months referred to in its first subparagraph to approve or reject the national provisions concerning the five elements (lead, arsenic, mercury, barium and antimony, as well as for nitrosamines and nitrosatable substances), notified by Germany on 2 March 2011, pursuant to Article 114(4), is extended until 5 March 2012.
V skladu s tretjim pododstavkom člena 114(6) PDEU se šestmesečno obdobje iz prvega pododstavka navedenega člena za odobritev ali zavrnitev nacionalnih določb o petih prvinah (svincu, arzenu, živem srebru, bariju in antimonu) ter nitrozaminih in nitrozabilnih snoveh, o katerih je Nemčija 2. marca 2011 v skladu s členom 114(4) uradno obvestila Komisijo, podaljša do 5. marca 2012.
Done at Brussels, 4 August 2011.
V Bruslju, 4. avgusta 2011
OJ C 159, 28.5.2011, p. 23.
UL C 159, 28.5.2011, str. 23.
According to Article 54, Member States shall bring into force national provisions complying with this Directive by 20 January 2011, and they shall apply them as from 20 July 2011.
V skladu s členom 54 države članice uveljavijo zakone in druge predpise, potrebne za uskladitev s to direktivo, do 20. januarja 2011 in jih uporabljajo od 20. julija 2011.
Part III of Annex II to the Directive will be applicable as from 20 July 2013.
Del III Priloge II k Direktivi se uporablja od 20. julija 2013.
A complete justification of the request has been sent by the German Federal Government with letter from the Office of its Permanent Representative, dated 2 March 2011.
Popolno utemeljitev vloge je z dopisom iz stalnega predstavništva poslala 2. marca 2011.
The detailed justification contained several annexes including scientific studies on the health assessment of the abovementioned substances from the Bundesinstitut für Risikobewertung (hereinafter ‘BfR’), dating January 2011.
Podrobna utemeljitev je vsebovala številne priloge, vključno z znanstvenimi študijami o tveganju navedenih snovi za zdravje, ki jih je pripravil zvezni inštitut za oceno tveganja (Bundesinstitut für Risikobewertung; v nadaljnjem besedilu: BfR), iz januarja 2011.
The Commission started the preparatory work for this amendment and the preliminary impact assessment report will be presented for discussion during the next meeting with Member States experts in October 2011.
Komisija je začela s pripravljalnimi deli za to spremembo, začasno poročilo o oceni učinka pa bo predstavljeno in obravnavano na naslednjem zasedanju s strokovnjaki držav članic oktobra 2011.
A formal proposal is planned for adoption in the first half of 2012.
Sprejetje uradnega predloga je načrtovano v prvi polovici leta 2012.
As indicated in Article 55 of the Directive, point 8 and 13 of part III, Annex II will be applicable from 20 July 2013.
V skladu s členom 55 Direktive se točki 8 in 13 dela III Priloge II uporabljata od 20. julija 2013.
Until 20 July 2013, the current provisions related to lead, antimony, barium, arsenic and mercury laid down in Directive 88/378/EEC and in the Second Equipment and Product Safety Act Ordinance (Verordnung über die Sicherheit von Spielzeug – 2. GPSGV) will apply.
Do 20. julija 2013 se uporabljajo veljavne določbe za svinec, antimon, barij, arzen in živo srebro iz Direktive 88/378/EGS ter iz Druge odredbe k Zakonu o varnosti naprav in izdelkov (Verordnung über die Sicherheit von Spielzeug - 2. GPSGV).
Whereas: FACTS
DEJSTVA
of 17 August 2011
z dne 17. avgusta 2011
Having regard to Regulation (EC) No 223/2009 of the European Parliament and of the Council of 11 March 2009 on European statistics [1] and in particular Article 23 thereof,
ob upoštevanju Uredbe (ES) št. 223/2009 Evropskega parlamenta in Sveta z dne 11. marca 2009 o evropski statistiki [1] in zlasti členu 23 Uredbe,
Commission Regulation (EC) No 831/2002 [2], concerning access to confidential data for scientific purposes establishes, for the purpose of enabling statistical conclusions to be drawn for scientific purposes, the conditions under which access to confidential data transmitted to the Community authority may be granted and the rules of cooperation between the Community and national authorities in order to facilitate such access.
Uredba Komisije št. (ES) 831/2002 [2] glede dostopa do zaupnih podatkov v znanstvene namene za omogočanje statističnih ugotovitev v znanstvene namene določa pogoje, pod katerimi se lahko dodeli dostop do zaupnih podatkov, poslanih organu Skupnosti, in pravila sodelovanja med Skupnostjo in nacionalnimi organi za lajšanje takega dostopa.
Commission Decision 2004/452/EC [3] has laid down a list of bodies whose researchers may access confidential data for scientific purposes.
Odločba Komisije 2004/452/ES [3] določa seznam organov, katerih raziskovalci imajo dostop do zaupnih podatkov v znanstvene namene.
Social Protection, Social Inclusion Strategy Unit, Directorate-General for Employment, Social Affairs and Inclusion of the European Commission and Institute for Fiscal Studies (Instituto de Estudios Fiscales — IEF), Madrid, Spain, have to be regarded as bodies fulfilling the required conditions and should therefore be added to the list of agencies, organisations and institutions referred to in Article 3(1)(e) of Regulation (EC) No 831/2002.
Šteje se, da sta Enota „Socialna zaščita in strategija za socialno vključenost“ Generalnega direktorata za zaposlovanje, socialne zadeve in vključevanje Evropske komisije ter Inštitut za davčne študije (Instituto de Estudios Fiscales – IEF), Madrid, Španija organa, ki izpolnjujeta zahtevane pogoje in ju je zato treba vključiti v seznam agencij, organizacij in institucij iz člena 3(1)(e) Uredbe (ES) št. 831/2002.
The measures provided for in this Decision are in accordance with the opinion of the European Statistical System Committee (ESS Committee),
Ukrepi, določeni s tem sklepom so v skladu z Odborom za evropski statistični sistem („Odbor ESS“) –
Done at Brussels, 17 August 2011.
V Bruslju, 17. avgusta 2011
Employment Analysis Unit, Directorate-General for Employment, Social Affairs and Equal Opportunities of the European Commission
Oddelek za analizo politike zaposlovanja Generalnega direktorata za zaposlovanje, socialne zadeve in enake možnosti Evropske komisije
Econometrics and Statistical Support to Antifraud (ESAF) Unit, Directorate-General Joint Research Centre of the European Commission
Enota ‚Ekonometrija in statistična podpora boju proti goljufijam‘ (ESAF) Generalnega direktorata Evropske komisije Skupno raziskovalno središče
Support to the European Research Area (SERA) Unit, Directorate-General Joint Research Centre of the European Commission
Enota ‚Podpora evropskemu raziskovalnemu prostoru‘ (SERA) Generalnega direktorata Skupno raziskovalno središče Evropske komisije
Directorate for Research, Studies and Statistics (Direction de l’Animation de la Recherche, des Études et des Statistiques — DARES) in the Ministry of Labour, Labour Relations and Solidarity, Paris, France
Direktorat za raziskave, študije in statistike (Direction de l’Animation de la Recherche, des Études et des Statistiques – DARES) na ministrstvu za delo, delovna razmerja in solidarnost, Pariz, Francija
Finnish Centre for Pensions, (Eläketurvakeskus — ETK), Finland
Finnish Centre for Pensions, (Eläketurvakeskus – ETK), Finska
Directorate for Research, Studies, Assessment and Statistics (Direction de la Recherche, des Études, de l’Évaluation et des Statistiques — DREES) in the Ministry of Labour, social dialogue and solidarity, the Ministry of Health, youth and sports and the Ministry of Budget, public accounts and state reform, Paris, France
Direktorat za raziskave, študije, vrednotenje in statistiko (Direction de la Recherche, des Études, de l’Évaluation et des Statistiques – DREES) na ministrstvu za delo, socialni dialog in solidarnost, ministrstvu za zdravje, mladino in šport ter ministrstvu za proračun, javne finance in državno reformo, Pariz, Francija
Duke University (DUKE), North Carolina, USA
Duke University (DUKE), North Carolina, ZDA
Social Insurance Institution of Finland (Kansaneläkelaitos — KELA), Finland
Social Insurance Institution of Finland (Kansaneläkelaitos – KELA), Finska
Federal Public Service Social Security, Belgium
Federal Public Service Social Security, Belgija
Directorate Economic Service and Structural Reforms, Directorate-General for Economic and Financial Affairs of the European Commission
Direktorat Gospodarska služba in strukturne reforme, Generalni direktorat za gospodarske in finančne zadeve Evropske komisije
Social Protection, Social Inclusion Strategy Unit, Directorate-General for Employment, Social Affairs and Inclusion of the European Commission
Enota ‚Socialna zaščita in strategija za socialno vključenost‘ Generalnega direktorata za zaposlovanje, socialne zadeve in vključevanje Evropske komisije
Institute for Fiscal Studies (Instituto de Estudios Fiscales — IEF), Madrid, Spain’
Inštitut za davčne študije (Instituto de Estudios Fiscales – IEF), Madrid, Španija“
of 18 August 2011
z dne 18. avgusta 2011
amending Annex I to Decision 2004/211/EC as regards the entries for Bahrain and Lebanon in the list of third countries and parts thereof from which the introduction into the Union of live equidae and semen, ova and embryos of the equine species are authorised
o spremembi Priloge I k Odločbi 2004/211/ES glede vnosov za Bahrajn in Libanon na seznamu tretjih držav in delov tretjih držav, iz katerih je dovoljen vnos živih enoprstih kopitarjev ter semena, jajčnih celic in zarodkov enoprstih kopitarjev v Unijo
Having regard to Council Directive 92/65/EEC of 13 July 1992, laying down animal health requirements governing trade in and imports into the Community of animals, semen, ova and embryos not subject to animal health requirements laid down in specific Community rules referred to in Annex A(I) to Directive 90/425/EEC [1], and in particular Article 17(3)(a) thereof,
ob upoštevanju Direktive Sveta 92/65/EGS z dne 13. julija 1992 o zahtevah zdravstvenega varstva živali za trgovino in za uvoz v Skupnost živali, semena, jajčnih celic in zarodkov, za katere ne veljajo zahteve zdravstvenega varstva živali, določene v posebnih pravilih Skupnosti iz Priloge A(I) k Direktivi 90/425/EGS [1], in zlasti člena 17(3)(a) Direktive,
Having regard to Council Directive 2009/156/EC of 30 November 2009 on animal health conditions governing the movement and importation from third countries of equidae [2], and in particular Article 12(1) and (4), and the introductory phrase of Article 19 and points (a) and (b) of Article 19 thereof,
ob upoštevanju Direktive Sveta 2009/156/ES z dne 30. novembra 2009 o pogojih v zvezi z zdravstvenim varstvom živali, ki ureja premike in uvoz kopitarjev iz tretjih držav [2], in zlasti člena 12(1) in (4), uvodnega stavka člena 19 ter točk (a) in (b) člena 19 Direktive,
Directive 92/65/EEC lays down conditions applicable to imports of animals, semen, ova and embryos.
Direktiva 92/65/EGS določa pogoje, ki se uporabljajo za uvoz živali, semena, jajčnih celic in zarodkov.
Those conditions are to be at least equivalent to those applicable to trade between Member States.
Navedeni pogoji morajo biti vsaj enakovredni tistim, ki se uporabljajo za trgovino med državami članicami.
Directive 2009/156/EC lays down animal health conditions for the importation into the Union of live equidae.
Direktiva 2009/156/ES določa pogoje v zvezi z zdravstvenim varstvom živali za uvoz živih enoprstih kopitarjev v Unijo.
It provides that imports of equidae into the Union are only authorised from third countries which have been free from glanders for a period of six months.
Direktiva določa, da je uvoz enoprstih kopitarjev v Unijo dovoljen samo iz tretjih držav, kjer 6 mesecev ni bilo smrkavosti.
Commission Decision 2004/211/EC of 6 January 2004 establishing the list of third countries and parts of territory thereof from which Member States authorise imports of live equidae and semen, ova and embryos of the equine species, and amending Decisions 93/195/EEC and 94/63/EC [3] establishes a list of third countries, or parts thereof where regionalisation applies, from which Member States are to authorise the importation of equidae and semen, ova and embryos thereof, and indicates the other conditions applicable to such imports.
Z Odločbo Komisije 2004/211/ES z dne 6. januarja 2004 o uvedbi seznama tretjih držav in delov njihovega ozemlja, s katerih države članice dovolijo uvoz živih kopitarjev in semena, jajčnih celic in zarodkov vrste kopitarji, ter o spremembi odločb 93/195/EGS in 94/63/ES [3] je bil uveden seznam tretjih držav ali, kjer se uporablja regionalizacija, delov tretjih držav, iz katerih države članice dovolijo uvoz enoprstih kopitarjev ter semena, jajčnih celic in zarodkov enoprstih kopitarjev, v njej pa so navedeni tudi drugi pogoji, ki se uporabljajo za tak uvoz.
That list is set out in Annex I to that Decision and includes registered horses and semen thereof from Lebanon.
Navedeni seznam je v Prilogi I k navedeni odločbi ter vključuje registrirane konje in njihovo seme iz Libanona.
The Regional Commission for the Middle East of the World Organisation for Animal Health (OIE) informed the Commission of the confirmation by an OIE Reference Laboratory of glanders (Burkholderia mallei) cases in equidae in Lebanon.
Regionalna komisija za Bližnji vzhod Svetovne organizacije za zdravje živali (OIE) je Komisijo obvestila, da je referenčni laboratorij OIE potrdil primere smrkavosti (Burkholderia mallei) pri enoprstih kopitarjih v Libanonu.
The introduction into the Union from Lebanon of registered horses and of semen thereof should therefore no longer be authorised.
Vnos registriranih konj in njihovega semena v Unijo iz Libanona zato ne sme biti več dovoljen.
Accordingly, it is necessary to amend the entry for Lebanon in the list set out in Annex I to Decision 2004/211/EC.
Vnos za Libanon na seznamu v Prilogi I k Odločbi 2004/211/ES je zato treba spremeniti.
In April 2010, the Commission received a report about confirmed cases of glanders in the northern parts of Bahrain.
Komisija je aprila 2010 prejela poročilo o potrjenih primerih smrkavosti v severnih delih Bahrajna.
In order to suspend the introduction into the Union of registered horses, their semen, ova and embryos, the Commission adopted Decision 2010/333/EU of 14 June 2010 amending Decision 2004/211/EC as regards the entries for Bahrain and Brazil in the list of third countries and parts thereof from which the introduction into the European Union of live equidae and semen, ova and embryos of the equine species are authorised [4].
Komisija je za zaustavitev vnosa v Unijo registriranih konj ter njihovega semena, jajčnih celic in zarodkov sprejela Sklep 2010/333/EU z dne 14. junija 2010 o spremembi Odločbe 2004/211/ES glede vnosov za Bahrajn in Brazilijo na seznamu tretjih držav in delov tretjih držav, iz katerih je dovoljen vnos živih kopitarjev in semena, jajčnih celic in zarodkov vrste kopitarji v Evropsko unijo [4].
A veterinary inspection mission carried out in Bahrain in June 2011 found sufficient evidence that Bahrain had implemented measures to control the disease in the north and that surveillance carried out throughout the territory of Bahrain confirmed the continued absence of this disease in the southern part of Bahrain.
Med veterinarskim pregledom, ki je bil junija 2011 izveden v Bahrajnu, je bil ugotovljen zadosten dokaz, da je Bahrajn izvedel ukrepe za nadzor bolezni v severnem delu države in da je nadzor, ki je bil izveden na celotnem ozemlju Bahrajna, potrdil stalno odsotnost te bolezni v južnem delu Bahrajna.
In addition, Bahrain has implemented movement controls, which include a strictly enforced ban on movements of equidae from the northern part of the territory of Bahrain into the southern part of the main island of Bahrain.
Poleg tega je Bahrajn uvedel nadzor premikov, ki vključuje dosledno izvajanje prepovedi premikov enoprstih kopitarjev iz severnega dela ozemlja Bahrajna v južni del glavnega otoka Bahrajna.
Consequently, it is possible to regionalise Bahrain in order to authorise the temporary admission and imports into the Union of registered horses from the southern part of the main island of Bahrain.
Bahrajn je zato možno regionalizirati, da se dovoli začasen sprejem in uvoz v Unijo registriranih konj iz južnega dela glavnega otoka Bahrajna.
Accordingly, it is necessary to amend the entry for Bahrain and to provide details of the delimitation of the southern part of the main island of Bahrain in the list set out in Annex I to Decision 2004/211/EC.
Vnos za Bahrajn je zato treba ustrezno spremeniti in na seznamu v Prilogi I k Odločbi 2004/211/ES navesti podrobnosti o razmejitvi južnega dela glavnega otoka Bahrajna.
the entry for Lebanon is replaced by the following:
vnos za Libanon se nadomesti z naslednjim:
Southern part of the main island of Bahrain
Južni del glavnega otoka Bahrajna
(see Box 4 for details)
(za podrobnejše informacije glej okence 4)
Box 4 is added in accordance with the Annex.
okence 4 se doda v skladu s Prilogo.
Done at Brussels, 18 August 2011.
V Bruslju, 18. avgusta 2011
The following Box 4 shall be added to Annex I to Decision 2004/211/EC:
V Prilogo I k Odločbi 2004/211/ES se doda naslednje okence 4:
‘Box 4:
„Okence 4:
Delimitation of the southern part of the main island of Bahrain
Razmejitev južnega dela glavnega otoka Bahrajna.
Northern boundary From the West coast at the end of Zallaq Highway at the entrance of Sofitel Hotel in an easterly direction along Zallaq Highway to the junction with SHK Khalifa Highway,
Severna razmejitvena črta Od konca ceste Zallaq pri vhodu v hotel Sofitel na zahodni obali proti vzhodu po cesti Zallaq do križišča s cesto SHK Khalifa,
proceeds along SHK Khalifa Highway in a northerly direction until the boundary of Al Rawdha, demarcated by the wall of the Kings Palace,
nato po cesti SHK Khalifa proti severu do meje Al Rawdha, ki jo predstavlja zid kraljeve palače,
proceeds along the boundaries of the area of Al Rawdha in easterly direction to the roundabout at Al Safra on the SHK Salman Highway and further in a southerly direction to the roundabout at the entrance to Awali village,
vzdolž meje območja Al Rawdha proti vzhodu do krožišča na cesti SHK Salman v kraju Al Safra in nato proti jugu do krožišča pri vhodu v vas Awali,
proceeds along Muaskar Highway in an easterly direction to the roundabout at Al Esteglal Highway/Hawar Highway and further in a southerly direction on Hawar Highway until that terminates at the eastern coast at the entrance of the village of Askar.
nato po cesti Muaskar proti vzhodu do krožišča, kjer se križata cesti Al Esteglal in Hawar, ter po cesti Hawar proti jugu do njenega konca na vzhodni obali pri vhodu v vas Askar.
Western boundary coast line
Zahodna razmejitvena črta obala
Eastern boundary coast line
Vzhodna razmejitvena črta obala
Southern boundary coast line’
Južna razmejitvena črta obala“
of 19 August 2011
z dne 19. avgusta 2011
authorising the placing on the market of Phosphatidylserine from soya phospholipids as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council
o odobritvi dajanja na trg fosfatidilserina iz sojinih fosfolipidov kot nove živilske sestavine v skladu z Uredbo (ES) št. 258/97 Evropskega parlamenta in Sveta
On 28 September 2009 the company Cantox Health Science International on behalf of the company Enzymotec Ltd made a request to the competent authorities of Finland to place Phosphatidylserine from soya phospholipids on the market as novel food ingredient.
Družba Cantox Health Science International je 28. septembra 2009 v imenu družbe Enzymotec Ltd pri pristojnih organih Finske vložila zahtevek za dajanje fosfatidilserina iz sojinih fosfolipidov na trg kot nove živilske sestavine.
On 14 April 2010 the competent food assessment body of Finland issued its initial assessment report.
Pristojni organ Finske za ocenjevanje živil je 14. aprila 2010 izdal poročilo o začetni presoji.
In that report it came to the conclusion that the company Enzymotec has provided sufficient information to authorise the placing on the market of Phosphatidylserine from soya phospholipids as a novel food ingredient.
V navedenem poročilu je ugotovil, da je družba Enzymotec predložila dovolj informacij, da se fosfatidilserin iz sojinih fosfolipidov lahko odobri za dajanje na trg kot nova živilska sestavina.
The Commission forwarded the initial assessment report to all Member States on 21 April 2010.
Komisija je 21. aprila 2010 vsem državam članicam poslala poročilo o začetni presoji.
Within the 60 days-period laid down in Article 6(4) of Regulation (EC) No 258/97, one reasoned objection to the marketing of the product, which concerns the maximum daily intake, was raised in accordance with that provision.
V skladu s členom 6(4) Uredbe (ES) št. 258/97 je bil v 60 dneh predložen en utemeljen ugovor zoper trženje proizvoda, in sicer glede največjega dnevnega vnosa.
In accordance with the provisions of Article 6(4) a Commission implementing Decision is required that takes into account the reasoned objection raised.
V skladu z določbami člena 6(4) je potreben izvedbeni sklep Komisije, ki naj upošteva predloženi utemeljeni ugovor.
Phosphatidylserine from soya phospholipids complies with the criteria laid down in Article 3(1) of Regulation (EC) No 258/97.
Fosfatidilserin iz sojinih fosfolipidov izpolnjuje merila iz člena 3(1) Uredbe (ES) št. 258/97.
Phosphatidylserine from soya phospholipids as specified in Annex I may be placed on the market in the Union as a novel food ingredient for the uses specified in Annex II.
Fosfatidilserin iz sojinih fosfolipidov, kakor je določen v Prilogi I, se lahko daje na trg Unije kot nova živilska sestavina za uporabe iz Priloge II.
The designation of Phosphatidylserine from soya phospholipids authorised by this Decision on the labelling of the foodstuff containing it shall be ‘Soya phosphatidylserine’.
Pri označevanju živil, ki vsebujejo fosfatidilserin iz sojinih fosfolipidov, odobren s tem sklepom, je označba zanj „sojin fosfatidilserin“.
Article 3
Člen 3 Ta sklep je naslovljen na Enzymotec Ltd, P.O.
This Decision is addressed to Enzymotec Ltd, P.O. Box 6, Migdal HaEmeq, 23106 Israel
Box 6, Migdal HaEmeq, 23106 Izrael
Done at Brussels, 19 August 2011.
V Bruslju, 19. avgusta 2011
Specifications of Phosphatidylserine from soya phospholipids
Specifikacije fosfatidilserina iz sojinih fosfolipidov
The novel food ingredient is an off-white to light yellow powder.
Nova živilska sestavina je sivobel do svetlorumen prašek.
It is also available in liquid form with a clear brown to orange colour.
Na voljo je tudi kot svetlorjava do oranžna tekočina.
The liquid form contains medium chain triacylglycerides (MCT) as a carrier.
Tekoča oblika za nosilec vsebuje srednjeverižne triacilgliceride (MCT).
It contains lower levels of Phosphatidylserine due to the fact that it includes significant amounts of oil (MCT).
Ima nižje ravni fosfatidilserina, ker vsebuje precejšnje količine olja (MCT).
Phosphatidylserine from soya phospholipids is obtained through enzymatic transphosphatidylation of high-phosphatidylcholine soybean lecithin with the amino acid L-serine.
Fosfatidilserin iz sojinih fosfolipidov se pridobi z encimsko transfosfatidilacijo sojinega lecitina z visoko vsebnostjo visokega fosfatidilholina z aminokislino L-serin.
Phosphatidylserine consists of a glycerophosphate skeleton conjugated with two fatty acids and L-serine via a phosphodiester linkage.
Fosfatidilserin sestoji iz glicerofosfatnega ogrodja, konjugiranega z dvema maščobnima kislinama in L-serinom s fosfodiestrsko vezjo.
Structural Formula:
Strukturna formula:
R=Fatty Acids
R=maščobne kisline
Characteristics of Phosphatidylserine from soya phospholipids
Značilnosti fosfatidilserina iz sojinih fosfolipidov
Powder Form
V obliki prahu
Liquid Form
V tekoči obliki
Moisture
vlaga
less than 2 %
manj kot 2 %
not less than 85 %
najmanj 85 %
not less than 25 %
najmanj 25 %
Phosphatidylserine
fosfatidilserin
not less than 61 %
najmanj 61 %
not less than 20 %
najmanj 20 %
Glycerides
gliceridi
not applicable
ni relevantno
free L-serine
prosti L-serin
less than 1 %
manj kot 1 %
Tocopherols
tokoferoli
less than 0,3 %
manj kot 0,3 %
Phytosterols
fitosteroli
less than 0,2 %
manj kot 0,2 %